The positivity of HER2 expression (including membranous and cytoplasmic expression) in CRC ranged from 1.3 to 82% owing to different detection methods and scoring systems (Richman et al. 2016; McKay et al. 2002; Blok et al. 2013). The gene discussed is ERBB2; the disease is colorectal carcinoma.